Literature DB >> 7632217

A second locus for Marfan syndrome maps to chromosome 3p24.2-p25.

G Collod1, M C Babron, G Jondeau, M Coulon, J Weissenbach, O Dubourg, J P Bourdarias, C Bonaïti-Pellié, C Junien, C Boileau.   

Abstract

Marfan syndrome (MFS) is an autosomal dominant connective-tissue disorder characterized by skeletal, ocular and cardiovascular defects of highly variable expressivity. The diagnosis relies solely on clinical criteria requiring anomalies in at least two systems. By excluding the chromosome 15 disease locus, fibrillin 1 (FBN1), in a large French family with typical cardiovascular and skeletal anomalies, we raised the issue of genetic heterogeneity in MFS and the implication of a second locus (MFS2). Linkage analyses, performed in this family, have localized MFS2 to a region of 9 centiMorgans between D3S1293 and D3S1283, at 3p24.2-p25. In this region, the highest lod score was found with D3S2336, of 4.89 (theta = 0.05). By LINKMAP analyses, the most probable position for the second locus in MFS was at D3S2335.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7632217      PMCID: PMC2045693          DOI: 10.1038/ng1194-264

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  34 in total

1.  A second-generation linkage map of the human genome.

Authors:  J Weissenbach; G Gyapay; C Dib; A Vignal; J Morissette; P Millasseau; G Vaysseix; M Lathrop
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

2.  The cardiovascular aspects of Marfan's syndrome: a heritable disorder of connective tissue.

Authors:  V A McKUSICK
Journal:  Circulation       Date:  1955-03       Impact factor: 29.690

3.  Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene.

Authors:  H C Dietz; G R Cutting; R E Pyeritz; C L Maslen; L Y Sakai; G M Corson; E G Puffenberger; A Hamosh; E J Nanthakumar; S M Curristin
Journal:  Nature       Date:  1991-07-25       Impact factor: 49.962

Review 4.  The Marfan syndrome: diagnosis and management.

Authors:  R E Pyeritz; V A McKusick
Journal:  N Engl J Med       Date:  1979-04-05       Impact factor: 91.245

5.  Two mutations in Marfan syndrome resulting in truncated fibrillin polypeptides.

Authors:  K Kainulainen; L Y Sakai; A Child; F M Pope; L Puhakka; L Ryhänen; A Palotie; I Kaitila; L Peltonen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

6.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

7.  Linkage of autosomal dominant dystrophic epidermolysis bullosa in three British families to the marker D3S2 close to the COL7A1 locus.

Authors:  L al-Imara; A J Richards; R A Eady; I M Leigh; M Farrall; F M Pope
Journal:  J Med Genet       Date:  1992-06       Impact factor: 6.318

8.  Quantitative differences in biosynthesis and extracellular deposition of fibrillin in cultured fibroblasts distinguish five groups of Marfan syndrome patients and suggest distinct pathogenetic mechanisms.

Authors:  T Aoyama; U Francke; H C Dietz; H Furthmayr
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

9.  Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes.

Authors:  B Lee; M Godfrey; E Vitale; H Hori; M G Mattei; M Sarfarazi; P Tsipouras; F Ramirez; D W Hollister
Journal:  Nature       Date:  1991-07-25       Impact factor: 49.962

10.  Encyclopedia of the mouse genome III. October 1993. Mouse chromosome 16.

Authors:  R H Reeves; N G Irving; R D Miller
Journal:  Mamm Genome       Date:  1993       Impact factor: 2.957

View more
  27 in total

1.  Muscle fibrillin deficiency in Marfan's syndrome myopathy.

Authors:  W M H Behan; C Longman; R K H Petty; P Comeglio; A H Child; M Boxer; P Foskett; D G F Harriman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-05       Impact factor: 10.154

Review 2.  Genetic testing in aortic aneurysm disease: PRO.

Authors:  Dianna M Milewicz; Alicia A Carlson; Ellen S Regalado
Journal:  Cardiol Clin       Date:  2010-05       Impact factor: 2.213

Review 3.  The molecular genetics of Marfan syndrome and related microfibrillopathies.

Authors:  P N Robinson; M Godfrey
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

4.  Aortic dimensions and the risk of dissection.

Authors:  Raimund Erbel; Holger Eggebrecht
Journal:  Heart       Date:  2006-01       Impact factor: 5.994

Review 5.  Marfan syndrome. Part 1: pathophysiology and diagnosis.

Authors:  Victoria Cañadas; Isidre Vilacosta; Isidoro Bruna; Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2010-03-30       Impact factor: 32.419

Review 6.  Marfan syndrome.

Authors:  J R Gray; S J Davies
Journal:  J Med Genet       Date:  1996-05       Impact factor: 6.318

7.  Reply to "The question of heterogeneity in Marfan syndrome"

Authors:  Catherine Boileau; Claudine Junien; Gwenaëlle Collod; Guillaume Jondeau; Olivier Dubourg; Jean-Pierre Bourdarias; Catherine Bonaïti-Pellié; Jean Frezal; Pierre Maroteaux
Journal:  Nat Genet       Date:  1995-03       Impact factor: 38.330

8.  Mapping of a congenital microcoria locus to 13q31-q32.

Authors:  C Rouillac; O Roche; D Marchant; L Bachner; A Kobetz; P J Toulemont; C Orssaud; M Urvoy; S Odent; B Le Marec; M Abitbol; J L Dufier
Journal:  Am J Hum Genet       Date:  1998-05       Impact factor: 11.025

9.  Marfan syndrome.

Authors:  G Galasko
Journal:  J Med Genet       Date:  1996-12       Impact factor: 6.318

10.  Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26.

Authors:  H Ikeda; T Sasaki; T Yoshimoto; M Fukui; T Arinami
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.